Congratulations to The #PressAwards Health Journalist category winner Sarah Neville / Financial Times

About a decade ago, Silicon Valley’s billionaires turned their attention to defeating death. Today, Philanthropist Nicole Shanahan is spending $100mn to find answers to fundamental questions about ovaries: on.ft.com/48WIROX

UK government eyes AstraZeneca manufacturing expansion deal, after drugmaker blamed a 'discouraging tax rate' for choosing Ireland over the UK for a previous factory.

With George Parker

ft.com/content/d99166…

We are at risk of yo-yoing between attention and neglect if pandemic preparedness becomes a political issue. Interesting interview with the chair of the 100 days mission by Ian Johnston

ft.com/content/b2cc3b…

As record numbers go to the polls in 2024, the FT launches a debate on what’s at stake with short films by four renowned artists

via @ft Juliet Riddell roula khalaf

ft.com/content/19e1ae…

News to kick off 2024: I've started as a pharmaceutical correspondent for the Financial Times, covering Hannah Kuchler for most of the year ahead. I'm very keen to chat to people in the pharma and biotech sector. If that's you, do get in touch!

“The company knew that these drugs were important. They worked on them for 30 years. But they did not know how big they were going to be,” says the Financial Times’s Hannah Kuchler on this week’s Behind the Money, about megablockbusters #Wegovy and #Ozempic

🎧: link.chtbl.com/ftbehind-the-m…

Only a few more days left to apply for the @financialtimes' amazing trainee scheme - the Paul McClean graduate trainee programme ft.com/content/314ff7… via @ft

And me!

Only a few more days to apply for the Paul McClean graduate trainee programme at the FT this year - this is one of the great entry jobs in journalism. A remarkable opportunity ft.com/content/314ff7…

DeepMind spin-off aims to halve drug discovery times following Big Pharma deals via Financial Times
on.ft.com/3tSyc8E

The costly and controversial outsourcing of mental health in England:
Spending on private “out of area” beds by NHS mental health trusts has reached record levels in the UK, and is 43 per cent higher than it was five years ago. W/ Amy Borrett 1/3
ft.com/content/c10f08…

Japan’s development bank makes first UK life sciences investment

ft.com/content/d99432…

Ready to Sort Your Financial Life out in 2024? Get my money course from the Financial Times in your inbox every Wednesday, FAQs below, sign up here: ft.com/moneycourse

A century ago the makers of insulin promised not to make “nasty profits”. This commitment created what is the world’s largest charitable foundation, fuelled by the latest big medical development: anti-obesity drug ⁦Financial Times⁩ ⁦Hannah Kuchler⁩
on.ft.com/3vkjWpw